Although chronic activation of NF-κB is linked to astrocytes' neurotoxic and pro-inflammatory phenotype, the sustained inhibition of NF-κB signaling suppresses astrocyte plasticity, effectively hindering its capacity to react appropriately to the changes in AD. The gene discussed is NFKB1; the disease is Alzheimer disease.